Saturday Coverage: Tech-Check-Tech, a Contraceptive Request, and a Warfarin Teach-Back

Not in this store, on this day. Final verification is the pharmacist's non-delegable accuracy determination: it is the point at which a licensed professional certifies that the drug, strength, quantity, directions, and patient match the prescriber's intent. Colorado permits pharmacists to delegate defined tasks to registered technicians, but delegation transfers the task, not the judgment. If any technician product-verification program exists in Colorado, it operates only under explicit Board-authorized conditions, documented training, and a store-level approval - none of which exist here.

Similarly, therapeutic counseling belongs to the pharmacist. Technicians may discuss wait times, price, refill status, and logistics; they may not explain a new drug's side effects, interactions, or monitoring. An intern may counsel as part of supervised training, with the pharmacist retaining responsibility, but that does not solve the queue problem.

The staffing pattern is the real violation. If the pharmacist leaves the counter to run vaccines in a way that leaves no pharmacist available to verify and counsel, the pharmacy is effectively dispensing without pharmacist oversight. Options: stagger the vaccine appointments, add a second pharmacist for the block, move the vaccines to a scheduled clinic with dedicated coverage, or reduce hours. The pharmacist remains professionally answerable for every prescription that goes out under his or her name, and 'we were busy' does not mitigate a misfill.

Colorado authorizes pharmacists to furnish certain categories of medication independently, including hormonal contraception, naloxone, and tobacco cessation aids, under defined conditions: a standardized procedure or algorithm, a self-screening tool completed by the patient, blood pressure measurement, application of the CDC US Medical Eligibility Criteria, documented referral criteria, and counseling on correct use and follow-up. The authority is bounded; the pharmacist cannot furnish outside the enumerated categories or skip the screening steps.

This patient fails the screen on at least three independent grounds for a combined hormonal product:

• Age 35 or older plus smoking 15 or more cigarettes daily - US MEC category 4 for combined hormonal contraception.
• Migraine with aura - category 4 for combined hormonal contraception because of stroke risk.
• Blood pressure 152/94 - uncontrolled hypertension, a further contraindication to estrogen-containing products.

So the answer is not a dispense. The pharmacist should not furnish a combined product, should document the specific screening findings and categories relied on, and should not simply send her away. Explain in plain language why the combined product is unsafe for her, note that progestin-only and long-acting options are generally less restricted with migraine with aura and that a clinician should evaluate the blood pressure, and provide a referral to a clinic or provider who can prescribe. Recheck the blood pressure and advise follow-up on the reading itself, since 152/94 in her forties is a finding she needs worked up regardless of contraception. Confidentiality and a non-judgmental tone are part of the standard.

Yes, with genuine pharmacist oversight. A registered intern may perform pharmacist functions, including patient counseling, as part of a supervised internship, provided the supervising pharmacist is licensed, physically present or available consistent with the practice setting, and accountable for the encounter. The intern cannot be the only professional coverage, and the pharmacist cannot be so far removed that the intern is de facto unsupervised.

What makes the supervision real:

• The pharmacist confirms the intern is registered and competent for this task before delegating it.
• The intern uses a structured approach for warfarin: indication, target INR and monitoring schedule, bleeding precautions, consistent vitamin K intake, clinically important interactions (antibiotics, NSAIDs, amiodarone, supplements), missed-dose instructions, and when to call.
• The pharmacist is available to step in, and does step in if the patient reveals complexity - a recent GI bleed, an INR of 6, a new antibiotic, or an inability to attend monitoring.
• The encounter and the supervision are documented: who counseled, who supervised, and what was covered.

Counseling a new anticoagulant is exactly the kind of high-consequence conversation that should not be used as an efficiency measure. If the pharmacist cannot be present enough to review the counseling, the counseling should be rescheduled or performed by the pharmacist, not handed off as a timesaver.